A randomized controlled trial of single-class maintenance therapy with abacavir/lamivudine/zidovudine after standard triple antiretroviral induction therapy: final 96-week results from the FREE study

Author:

Sprenger HG1,Langebeek N2,Mulder PGH3,ten Napel CHH4,Vriesendorp R5,Hoepelman AIM6,Legrand JC7,Koopmans PP8,Bravenboer B9,ten Kate RW10,Groeneveld PHP11,Bierman WFW1,van der Werf TS112,Gisolf EH2,Richter C2

Affiliation:

1. Department of Internal Medicine; Division of General Internal Medicine and Infectious Diseases; University of Groningen; University Medical Center Groningen; Groningen The Netherlands

2. Department of Internal Medicine; Infectious Diseases Service; Rijnstate Hospital; Arnhem The Netherlands

3. Department of Biostatistics; Erasmus Medical Center; Rotterdam The Netherlands

4. Department of Internal Medicine; Medical Spectrum Twente; Enschede The Netherlands

5. Department of Internal Medicine; Medical Center Haaglanden; The Hague The Netherlands

6. Department of Internal Medicine & Infectious Diseases; University Medical Center Utrecht; Utrecht The Netherlands

7. Charleroi University Hospital; AIDS Reference Center; Charleroi Belgium

8. Department of General Internal Medicine and Infectious Diseases; Radboud University Medical Center; Nijmegen The Netherlands

9. Department of Internal Medicine; Catharina Hospital; Eindhoven The Netherlands

10. Department of Internal Medicine; Kennemer Gasthuis; Haarlem The Netherlands

11. Department of Internal Medicine; Isala Clinics; Zwolle The Netherlands

12. Department of Pulmonary Disease and Tuberculosis; University of Groningen; University Medical Center Groningen; Groningen The Netherlands

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Abacavir ☆;Reference Module in Biomedical Sciences;2017

2. Antiviral Drugs;Side Effects of Drugs Annual;2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3